IL155410A0 - Stimulation of thymus for vaccination development - Google Patents

Stimulation of thymus for vaccination development

Info

Publication number
IL155410A0
IL155410A0 IL15541001A IL15541001A IL155410A0 IL 155410 A0 IL155410 A0 IL 155410A0 IL 15541001 A IL15541001 A IL 15541001A IL 15541001 A IL15541001 A IL 15541001A IL 155410 A0 IL155410 A0 IL 155410A0
Authority
IL
Israel
Prior art keywords
thymus
stimulation
vaccination
development
vaccination development
Prior art date
Application number
IL15541001A
Other languages
English (en)
Original Assignee
Univ Monash
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPR0745A external-priority patent/AUPR074500A0/en
Priority claimed from US09/755,965 external-priority patent/US20010046486A1/en
Application filed by Univ Monash filed Critical Univ Monash
Publication of IL155410A0 publication Critical patent/IL155410A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL15541001A 2000-10-13 2001-10-12 Stimulation of thymus for vaccination development IL155410A0 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US79530200A 2000-10-13 2000-10-13
US79528600A 2000-10-13 2000-10-13
AUPR0745A AUPR074500A0 (en) 2000-10-13 2000-10-13 Treatment of t cell disorders
US09/755,965 US20010046486A1 (en) 2000-04-17 2001-01-05 Stimulation of thymus for vaccination development
US09/965,394 US20020086000A1 (en) 1999-04-15 2001-09-26 Stimulation of thymus for vaccination development
PCT/IB2001/002350 WO2002030320A2 (en) 2000-10-13 2001-10-12 Stimulation of thymus for vaccination development

Publications (1)

Publication Number Publication Date
IL155410A0 true IL155410A0 (en) 2003-11-23

Family

ID=27507496

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15541001A IL155410A0 (en) 2000-10-13 2001-10-12 Stimulation of thymus for vaccination development

Country Status (11)

Country Link
US (1) US20020086000A1 (de)
EP (1) EP1355653A4 (de)
JP (1) JP2004517051A (de)
CN (1) CN1505522A (de)
AP (1) AP2003002797A0 (de)
AU (1) AU2002223106A1 (de)
BR (1) BR0114641A (de)
CA (1) CA2462027A1 (de)
IL (1) IL155410A0 (de)
NZ (1) NZ525825A (de)
WO (1) WO2002030320A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004094599A2 (en) * 2003-04-18 2004-11-04 Norwood Immunology, Ltd. Disease prevention and vaccination following thymic reactivation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69840637D1 (de) * 1997-12-11 2009-04-16 Univ Maryland Biotech Inst Zusammensetzungen zur steigerung der effizienz von impfstoffen unter verwendung von chemokinen
US20010046486A1 (en) * 2000-04-17 2001-11-29 Boyd Richard L. Stimulation of thymus for vaccination development
AUPP977899A0 (en) * 1999-04-15 1999-05-13 Monash University Improvement of t cell mediated immunity

Also Published As

Publication number Publication date
AP2003002797A0 (en) 2003-06-30
BR0114641A (pt) 2004-01-20
EP1355653A2 (de) 2003-10-29
US20020086000A1 (en) 2002-07-04
WO2002030320A2 (en) 2002-04-18
JP2004517051A (ja) 2004-06-10
EP1355653A4 (de) 2006-05-31
WO2002030320A3 (en) 2002-06-20
AU2002223106A1 (en) 2002-04-22
CN1505522A (zh) 2004-06-16
CA2462027A1 (en) 2002-04-18
NZ525825A (en) 2005-05-27

Similar Documents

Publication Publication Date Title
HUP0204250A3 (en) Use of hiv-protein or -polynucleotide for vaccine produce
GB2368019B (en) Apparatus for electrical stimulation of the body
HUP0103976A2 (hu) Új eljárások terápiás vakcinázásra
IL213240A0 (en) Method of treatment using lighnd-immunogen conjugates
AU5464601A (en) Treatment of scale
HUP0200527A2 (en) Use of antibodies for anticancer vaccination
GB2379395B (en) Cardiac stimulation apparatus
GB0026417D0 (en) Flame stimulation apparatus
IL155410A0 (en) Stimulation of thymus for vaccination development
SI1117421T1 (en) Methods for therapeutic vaccination
EP1303281A4 (de) Verfahren zur behandlung
EP1179002A4 (de) Methoden die mecahnismen der aroa gebrauchen
GB0013089D0 (en) Improved methods of transfection
GB2405099B (en) Cardiac stimulation apparatus
EG26505A (en) Generate precise therapeutic foam
CA96058S (en) Set of bathtub supports
TW471258U (en) Improved structure of feedbarrel for cattle
TW383596U (en) Improved structure of massager
GB9930024D0 (en) Method of vaccine preparation
GB0013928D0 (en) Methods of treatment
GB0014904D0 (en) Methods of treatment
TW406699U (en) Improved structure of artificial stone
GB9917181D0 (en) Methods of treatment
GB9901310D0 (en) Methods of treatment
TW422092U (en) Improved structure of massager